Astrocytes and Huntington's disease

33Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this Viewpoint, we summarize and discuss the recent serendipitous discovery of an astrocyte Kir4.1 potassium channel dysfunction in two mouse models of Huntington's disease (HD). Restoration of Kir4.1 channels within astrocytes in vivo attenuated neuronal dysfunction, some aspects of motor dysfunction and increased survival time in a HD mouse model. Overall, the data show that aspects of altered neuronal excitability associated with HD may be secondary to changes in astrocyte-mediated K+ homeostasis, thereby revealing a new striatal neural microcircuit mechanism in HD, and Kir4.1 channels and astrocytes as potential therapeutic targets for drug development. © 2014 American Chemical Society.

Cite

CITATION STYLE

APA

Khakh, B. S., & Sofroniew, M. V. (2014). Astrocytes and Huntington’s disease. ACS Chemical Neuroscience, 5(7), 494–496. https://doi.org/10.1021/cn500100r

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free